How Vanda Pharmaceuticals Inc (VNDA) Stock converts water flow into cash flow
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
Vanda Pharmaceuticals Inc (VNDA) Stock Experiences Incredible Growth
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
Faced with a depressed economy, Vanda Pharmaceuticals Inc (VNDA) Stock offers an opportunity
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
The growth of Vanda Pharmaceuticals Inc (VNDA) Stock is expected to continue
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
It’s Better to Hope for Prosperity than Become Adversary: Vanda Pharmaceuticals Inc (VNDA) Stock
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
The Vanda Pharmaceuticals Inc (VNDA) Stock expansion path ahead
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
Are Vanda Pharmaceuticals Inc’s (VNDA) stock prices rising too high?
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]